Zheng's laboratory focuses on Alzheimer's disease (AD), the main cause of dementia in the elderly. His team has been seeking to unveil how tau pathology is involved in the onset and progression of AD, and to develop tau-based therapeutic drugs. Besides, Dr. Zheng is also interested in tapping the potential of pro-neurogenic remedies for AD treatment.